Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    20361905 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression
Condition: Major Depressive Disorder
Interventions: Drug: Olanzapine;   Drug: Fluoxetine

Indicates status has not been verified in more than two years